We are live on ! Find out more
FWM

Filbrandt Wealth Management Portfolio holdings

AUM $174M
1-Year Est. Return 35.59%
This Fund
S&P 500
This Quarter Est. Return
-25.35%
1 Year Est. Return
+35.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$90.8M
AUM Growth
-$22.3M
Cap. Flow
+$8.81M
Cap. Flow %
9.7%
Top 10 Hldgs %
88.08%
Holding
333
New
142
Increased
36
Reduced
28
Closed
42

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.59%
2 Industrials 1.5%
3 Healthcare 1.18%
4 Technology 0.92%
5 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
226
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1K ﹤0.01%
+12
New +$1.08K
VMW
227
DELISTED
VMware, Inc
VMW
$1K ﹤0.01%
+6
New +$825
NEWR
228
DELISTED
New Relic, Inc.
NEWR
$1K ﹤0.01%
+14
New +$818
COUP
229
DELISTED
Coupa Software Incorporated
COUP
$1K ﹤0.01%
+8
New +$1.24K
ZEAL
230
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$1K ﹤0.01%
+25
New +$871
ZNGA
231
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1K ﹤0.01%
+150
New +$986
EPAY
232
DELISTED
Bottomline Technologies Inc
EPAY
$1K ﹤0.01%
+15
New +$691
ARNA
233
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1K ﹤0.01%
+30
New +$1.38K
PVG
234
DELISTED
PRETIUM RESOURCES INC.
PVG
$1K ﹤0.01%
+145
New +$1.24K
RDS.B
235
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1K ﹤0.01%
29
+1
+4% +$47
CLDR
236
DELISTED
Cloudera, Inc.
CLDR
$1K ﹤0.01%
+120
New +$1.17K
PGNX
237
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1K ﹤0.01%
+150
New +$646
GHDX
238
DELISTED
Genomic Health, Inc.
GHDX
$1K ﹤0.01%
+15
New +$1K
HZNP
239
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1K ﹤0.01%
+25
New +$846
SCA
240
DELISTED
SYNOCORA HOLDINGS LTD (BERMUDA)
SCA
$1K ﹤0.01%
+150
New +$1K
AA icon
241
Alcoa
AA
$13.5B
$0 ﹤0.01%
33
ACB
242
Aurora Cannabis
ACB
$237M
$0 ﹤0.01%
+2
New +$357
ADI icon
243
Analog Devices
ADI
$187B
-144
Closed -$17K
AGM.PRD icon
244
Federal Agricultural Mortgage Corp Series D
AGM.PRD
$85.4M
-1,000
Closed -$27K
ARKK icon
245
ARK Innovation ETF
ARKK
$6.44B
$0 ﹤0.01%
+10
New +$510
BDX icon
246
Becton Dickinson
BDX
$50B
-69
Closed -$18K
BHC icon
247
Bausch Health
BHC
$2.32B
$0 ﹤0.01%
+25
New +$603
BHF icon
248
Brighthouse Financial
BHF
$3.44B
$0 ﹤0.01%
20
BP icon
249
BP
BP
$111B
-5
Closed
BSV icon
250
Vanguard Short-Term Bond ETF
BSV
$45.6B
-485
Closed -$39K

Similar funds

Filbrandt Wealth Management's Q1 2020 Portfolio in Review

As of Q1 2020, Filbrandt Wealth Management held 333 positions worth $90.8M, down 20% from $113M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Filbrandt Wealth Management deployed $8.81M of net new capital in Q1 2020, opening 142 new positions and adding to 36 existing holdings. Its largest new stake was Sandstorm Gold: 7,100 shares worth $36K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.6% of assets, down from 1.9% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard Morningstar Mega Cap Value ETF, an estimated $189K trimmed.

  • Filbrandt Wealth Management's largest Q1 2020 buy was Sandstorm Gold: 7,100 shares worth $36K.
  • Filbrandt Wealth Management added most to Schwab US Large- Cap ETF in Q1 2020, an estimated $4.08M increase.
  • Filbrandt Wealth Management's biggest Q1 2020 reduction was Vanguard Morningstar Mega Cap Value ETF, cutting an estimated $189K.
  • Filbrandt Wealth Management fully exited Novartis in Q1 2020, selling an estimated $79K.
  • Filbrandt Wealth Management's ten largest holdings make up 88% of its $90.8M portfolio in Q1 2020.
  • Filbrandt Wealth Management opened 142 new positions and closed 42 in Q1 2020.
  • Filbrandt Wealth Management's portfolio value fell 20% quarter-over-quarter to $90.8M.

Based on Filbrandt Wealth Management's 13F filing for Q1 2020, filed 30 Apr 2020.